Q3 EPS Estimates for Teladoc Health Raised by Zacks Research

Teladoc Health, Inc. (NYSE:TDOC) – Equities research analysts at Zacks Research raised their Q3 2025 earnings estimates for shares of Teladoc Health in a research note issued on Tuesday, August 12th. Zacks Research analyst R. Department now forecasts that the health services provider will post earnings of ($0.24) per share for the quarter, up from their previous estimate of ($0.25). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health’s Q4 2025 earnings at ($0.18) EPS, FY2025 earnings at ($0.80) EPS, Q1 2026 earnings at ($0.29) EPS, Q2 2026 earnings at ($0.24) EPS, Q3 2026 earnings at ($0.27) EPS, Q4 2026 earnings at ($0.13) EPS, FY2026 earnings at ($0.93) EPS, Q1 2027 earnings at ($0.26) EPS, Q2 2027 earnings at ($0.23) EPS and FY2027 earnings at ($0.92) EPS.

A number of other equities research analysts also recently commented on the company. Citigroup decreased their target price on Teladoc Health from $11.00 to $8.75 and set a “neutral” rating for the company in a report on Friday, April 25th. Bank of America decreased their price objective on shares of Teladoc Health from $8.00 to $7.00 and set a “neutral” rating for the company in a research note on Wednesday, May 28th. Truist Financial dropped their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a “hold” rating on the stock in a report on Tuesday, May 27th. The Goldman Sachs Group cut their price objective on shares of Teladoc Health from $13.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday, May 1st. Finally, Wells Fargo & Company decreased their target price on shares of Teladoc Health from $10.00 to $8.00 and set an “equal weight” rating for the company in a research report on Thursday, May 8th. Twelve equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $9.76.

Teladoc Health Stock Performance

Shares of TDOC opened at $7.29 on Thursday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The stock has a 50-day moving average of $7.71 and a two-hundred day moving average of $8.34. The stock has a market cap of $1.29 billion, a P/E ratio of -6.12 and a beta of 1.76. Teladoc Health has a one year low of $6.35 and a one year high of $15.21.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. During the same period in the previous year, the firm posted ($0.38) earnings per share. The business’s revenue for the quarter was down 1.6% compared to the same quarter last year.

Institutional Trading of Teladoc Health

Institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC boosted its stake in shares of Teladoc Health by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock worth $35,894,000 after acquiring an additional 22,664 shares during the last quarter. Sterling Capital Management LLC lifted its holdings in Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after purchasing an additional 4,101 shares in the last quarter. Summit Investment Advisors Inc. boosted its stake in Teladoc Health by 8.0% during the 4th quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider’s stock worth $164,000 after purchasing an additional 1,331 shares during the last quarter. Mariner LLC grew its holdings in shares of Teladoc Health by 17.3% during the fourth quarter. Mariner LLC now owns 27,065 shares of the health services provider’s stock worth $246,000 after buying an additional 3,982 shares in the last quarter. Finally, Farringdon Capital Ltd. acquired a new stake in shares of Teladoc Health in the fourth quarter valued at about $149,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Insider Buying and Selling at Teladoc Health

In other news, insider Carlos Nueno sold 3,958 shares of the business’s stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the sale, the insider directly owned 17,645 shares in the company, valued at $121,044.70. The trade was a 18.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Fernando M. Rodrigues sold 4,174 shares of the stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. Over the last three months, insiders have sold 18,656 shares of company stock valued at $128,189. Company insiders own 0.58% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.